Journal of the National Cancer Institute Advance Access originally published online on August 8, 2007
JNCI Journal of the National Cancer Institute 2007 99(16):1213; doi:10.1093/jnci/djm134
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© Oxford University Press 2007.
MEMO TO THE MEDIA |
Press Release
Chemotherapy with Bevacizumab Increases Risk of Blood Clots in Arteries
jncimedia@oxfordjournals.org
301-841-1287
| The first 10% of the full text of this article appears below. |
Treatment with chemotherapy and bevacizumab, an anticancer drug, is associated with a greater risk of blood clots in patients arteries compared with treatment with chemotherapy only, according to a study published online August 7 in the Journal of the
Note to Reporters:
Related Article in JNCI
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2007 99: 1232-1239.